PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-2.80%
Revenue decline while Healthcare median is 0.00%. Seth Klarman would investigate if market share loss is temporary.
9.66%
Cost increase while Healthcare shows cost reduction. Peter Lynch would examine competitive disadvantages.
-41.28%
Gross profit decline while Healthcare median is 6.56%. Seth Klarman would investigate competitive position.
-39.59%
Margin decline while Healthcare median is 0.00%. Seth Klarman would investigate competitive position.
89.29%
R&D change of 89.29% versus flat Healthcare spending. Walter Schloss would verify adequacy.
-7.89%
G&A reduction while Healthcare median is 0.00%. Seth Klarman would investigate efficiency gains.
26.17%
Marketing expense change of 26.17% versus flat Healthcare spending. Walter Schloss would verify adequacy.
-1405.27%
Other expenses reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
-25.42%
Operating expenses reduction while Healthcare median is 0.87%. Seth Klarman would investigate advantages.
-2.94%
Total costs reduction while Healthcare median is 0.38%. Seth Klarman would investigate advantages.
-1.25%
Interest expense reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
4.09%
D&A change of 4.09% versus flat Healthcare D&A. Walter Schloss would verify adequacy.
-774.69%
EBITDA decline while Healthcare median is 3.52%. Seth Klarman would investigate causes.
86.17%
Margin change of 86.17% versus flat Healthcare. Walter Schloss would verify quality.
20.03%
Operating income growth exceeding 1.5x Healthcare median of 3.07%. Joel Greenblatt would investigate advantages.
17.73%
Margin change of 17.73% versus flat Healthcare. Walter Schloss would verify quality.
145.72%
Other expenses growth while Healthcare reduces costs. Peter Lynch would examine differences.
-117.61%
Pre-tax income decline while Healthcare median is 2.93%. Seth Klarman would investigate causes.
-123.88%
Pre-tax margin decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
15.06%
Tax expense change of 15.06% versus flat Healthcare. Walter Schloss would verify strategy.
-89.15%
Net income decline while Healthcare median is 2.33%. Seth Klarman would investigate causes.
-94.61%
Net margin decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
-78.84%
EPS decline while Healthcare median is 6.03%. Seth Klarman would investigate causes.
-78.84%
Diluted EPS decline while Healthcare median is 6.06%. Seth Klarman would investigate causes.
3.24%
Share count reduction below 50% of Healthcare median of 0.23%. Jim Chanos would check for issues.
3.24%
Diluted share reduction below 50% of Healthcare median of 0.27%. Jim Chanos would check for issues.